This is a temporary backup site for TRENDS MENA while our primary website is being restored following a regional disruption affecting AWS cloud infrastructure in the GCC.

Search Site

AD Ports Group 2024 net profit $484m

The Group's revenue increased 48 percent year-on-year.

TAQA net income $1.93bn in 2024

The company's revenues increased 6.7 percent year-on-year.

ADNOC L&S 2024 net profit $756m

The company's revenue increased by 29 percent to $3.54 billion.

ADNOC Distribution 2024 net profit down 7%

Minus UAE corporate tax, it would have grown by 2.4% to $725m

Maaden raises $1.25bn in sukuk offering

The Sukuk were offered in a five-year and a 10-year tranche.

Algeria begins Sinovac Covid-19 vaccine production

  • Lotfi Djamel Benbahmed, Algeria's minister for the pharmaceutical industry, has said the country plans to export the vaccines
  • Saidal, the firm making the jabs, was so far the only African company to be licenced to produce the jab

Algeria on Wednesday started producing the Covid-19 vaccine developed by Chinese firm Sinovac, with production expected to be eight million doses a month.

Prime Minister Aimene Benabderrahmane, who attended the launch of the production process at a factory in the eastern city of Constantine, called it a “big achievement”.

Production could be doubled in the North African nation if needed, officials said.

“Algeria… aims to achieve other projects of this kind,” Benabderrahmane said, praising the country’s pharmaceutical industry.

Lotfi Djamel Benbahmed, Algeria’s minister for the pharmaceutical industry, has said the country plans to export the vaccines.

He said Saidal, the firm making the jabs, was so far the only African company to be licenced to produce the jab.

Following a sharp spike in Covid-19 cases in past months, Algeria has seen a drop in recent weeks.

Algeria, the biggest African nation by size, announced this month a campaign to vaccinate some 70 percent of its 44 million population by the end of the year.